Glioblastoma is the most common form of brain cancer, and given that activated MET signaling/ MET alteration contributes significantly to glioblastoma 82, a thorough understanding of the MET signaling pathway is required to identify functional therapeutic targets to aid the development of effective treatment for this disease. Here, MET is linked to brain cancer.